Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
14 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-announces-2025-annual-meeting-of-shareholder-results-1027968
06 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/xifaxanr-rifaximin-treatment-following-overt-hepatic-encephalopathy-o-1023754
30 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-announces-first-quarter-2025-results-1021591
23 Apr 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/bausch-health-after-setting-poison-pill-defend-against-unwanted-takeovers-reveals-activist
17 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/us-district-court-grants-summary-judgment-in-favor-of-fda-salix-and-t-1016430
14 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-announces-adoption-of-shareholder-rights-plan-1014667
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CREAM
Dosage Strength : 5%/W/W
Packaging : 5G
Brand Name : ZOVIRAX
Approval Date :
Application Number : 2039524
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : OINTMENT
Dosage Strength : 5%/W/W
Packaging : 4G/30G
Brand Name : ZOVIRAX
Approval Date :
Application Number : 569771
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CREAM
Dosage Strength : 5%/W/W
Packaging : 5G
Brand Name : XERESE
Approval Date :
Application Number : 2404044
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : GEL
Dosage Strength : 0.15%/W/W
Packaging :
Brand Name : CABTREO
Approval Date :
Application Number : 2550423
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Dosage Form : TABLET
Dosage Strength : 40MG
Packaging :
Brand Name : EDARBYCLOR
Approval Date :
Application Number : 2397749
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Dosage Form : TABLET
Dosage Strength : 40MG
Packaging :
Brand Name : EDARBYCLOR
Approval Date :
Application Number : 2397765
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Dosage Form : TABLET
Dosage Strength : 40MG
Packaging :
Brand Name : EDARBI
Approval Date :
Application Number : 2381389
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Dosage Form : TABLET
Dosage Strength : 80MG
Packaging :
Brand Name : EDARBI
Approval Date :
Application Number : 2381397
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CREAM
Dosage Strength : 0.025%/W/W
Packaging :
Brand Name : PROPADERM
Approval Date :
Application Number : 2089602
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : METERED-DOSE AEROSOL
Dosage Strength : 50MCG/ACT
Packaging :
Brand Name : QVAR
Approval Date :
Application Number : 2242029
Regulatory Info : Prescription
Registration Country : Canada
Inspections and registrations
ABOUT THIS PAGE
Dow Pharmaceutical Sciences, Inc is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Metformin bulk with DMF offered by Dow Pharmaceutical Sciences, Inc
Find a price of Pyridostigmine bulk with DMF offered by Dow Pharmaceutical Sciences, Inc
Find a price of Nitrazepam bulk offered by Dow Pharmaceutical Sciences, Inc